The incidence of childhood leukaemia around the La Hague nuclear waste reprocessing plant (France): a survey for the years 1978–1998

BACKGROUND A previous study has suggested an increased incidence rate of leukaemia from 1978 to 1992 in people aged 0 to 24 years and living in the vicinity of the La Hague nuclear waste reprocessing plant without considering age and cytological type. SETTING The Nord Cotentin region (France) and the island of Alderney (United Kingdom). STUDY OBJECTIVE To describe the occurrence of leukaemia for each age group and cytological type from 1978 to 1998 in the same area, using accurate reference incidence rates and adequate estimation of the at risk population. DESIGN A geographical study of incidence using three zones defined according to their distance from the site (0 to 10 km: Beaumont-Hague electoral ward, 10 to 20 km and 20 to 35 km) has been conducted. The risk of leukaemia was estimated from the standardised incidence ratio (SIR) of the number of cases observed to the number expected. Exact 95% confidence intervals (CI) have been computed. PARTICIPANTS All people under the age of 25 years living in the study region between 1978 and 1998. MAIN RESULTS The observed number of cases of leukaemia in the study region as a whole was consistent with the expected value (SIR=1.03; 95%CI: 0.73, 1.41). No cases were observed on Alderney. The SIR in the Beaumont-Hague electoral ward was 2.17 (95%CI: 0.71, 5.07). The highest SIR was observed in the 5 to 9 years age group (SIR=6.38; 95%CI: 1.32, 18.65). This consists in acute lymphoblastic leukaemia cases. CONCLUSION This study indicates an increased incidence of leukaemia in the area situated at less than 10 km from the plant. Monitoring and further investigations should be targeted at acute lymphoblastic leukaemia occurring during the childhood incidence peak (before 10 years) in children living near the La Hague site and may be other nuclear reprocessing plants.

[1]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[2]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[3]  M. Contreras,et al.  ABO STATUS AND T-CELL HELP , 1985, The Lancet.

[4]  E D Rubery,et al.  Investigation of the possible increased incidence of cancer in West Cumbria , 1985 .

[5]  E. Somers International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[6]  J. Urquhart,et al.  CHILDHOOD LEUKAEMIA IN NORTHERN SCOTLAND , 1986, The Lancet.

[7]  L. Garfinkel Cancer incidence in five continents. Volume 3 Edited by J. Waterhouse, C. Muir, P. Correa, J. Powell. IARC Scientific Publication No. 15. International Agency for Research on Cancer, Lyon, 1976, 584 pp. U.S. $40.00, SW. Fr. 100 , 1978 .

[8]  Leo Kinlen,et al.  EVIDENCE FOR AN INFECTIVE CAUSE OF CHILDHOOD LEUKAEMIA: COMPARISON OF A SCOTTISH NEW TOWN WITH NUCLEAR REPROCESSING SITES IN BRITAIN , 1988, The Lancet.

[9]  B. Greenwood Population at risk. , 1990, Parasitology today.

[10]  J. Viel,et al.  Childhood leukaemia around the La Hague nuclear waste reprocessing plant. , 1990, BMJ.

[11]  A J Hall,et al.  Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. , 1990, BMJ.

[12]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[13]  D. Pottier Cancer Incidence in Five Continents. Population-at-risk. , 1992, IARC scientific publications.

[14]  J. Bernard,et al.  Childhood cancer incidence in the south-east of France. A report of the Provence-Alpes-Côte d'Azur and Corsica Regions Pediatric Cancer Registry, 1984-1991. , 1993, European journal of cancer.

[15]  M. Greaves,et al.  An infectious etiology for common acute lymphoblastic leukemia in childhood? , 1993, Leukemia.

[16]  S. C. Darby,et al.  Paternal exposure not to blame , 1994, Nature.

[17]  J F Viel,et al.  Incidence of leukaemia in young people around the La Hague nuclear waste reprocessing plant: a sensitivity analysis. , 1995, Statistics in medicine.

[18]  R Wakeford Leukaemia near La Hague nuclear plant. Scientific context is needed. , 1997, BMJ.

[19]  M. Horwitz,et al.  The genetics of familial leukemia , 1997, Leukemia.

[20]  D Hémon,et al.  Leukaemia near La Hague nuclear plant , 1997, BMJ.

[21]  J. Viel,et al.  Case-control study of leukaemia among young people near La Hague nuclear reprocessing plant: the environmental hypothesis revisited , 1997, BMJ.

[22]  A Spira,et al.  [Incidence of leukemias in people aged 0 to 24 in north Cotentin]. , 1997, Revue d'epidemiologie et de sante publique.

[23]  N. Chaturvedi,et al.  Study design and nature of diabetes may explain findings of Finnish study , 1997, BMJ.

[24]  Jacques Ferlay,et al.  Cancer incidence in five continents, Volume IX. , 1982 .

[25]  G. Law,et al.  Leukaemia near La Hague nuclear plant. Study design is questionable. , 1997, BMJ.

[26]  C. Barton,et al.  Leukaemia near La Hague nuclear plant. Case-control studies have been done in Britain. , 1997, BMJ.

[27]  J. Viel Criticism of study of childhood leukaemia near French nuclear reprocessing plant is unfounded , 1997, BMJ.

[28]  Richard Doll,et al.  The Seascale cluster: a probable explanation , 1999, British Journal of Cancer.

[29]  D. Laurier,et al.  Epidemiologic studies of leukemia among persons under 25 years of age living near nuclear sites. , 1999, Epidemiologic reviews.

[30]  L. Parker,et al.  Quantifying the effect of population mixing on childhood leukaemia risk: the Seascale cluster , 1999, British Journal of Cancer.

[31]  A Sugier,et al.  Methodology and results of the Nord-Cotentin radioecological study , 2000, Journal of radiological protection : official journal of the Society for Radiological Protection.

[32]  H. Hasle,et al.  Risks of leukaemia and solid tumours in individuals with Down's syndrome , 2000, The Lancet.